Announcement looks fairly decent.
i'm more just pleased we can put the debate myself and scarpa were having around strip ratio. The debate being that it would be higher than KDR's and closer to 5-7;1. additionally debate was that "pre-stripping" would improve the economics. My argument being that pre-stripping is a part of every operation (unless it's at surface) and that the strip ratio in the PFS would be higher as typically it's presented in a LOM case.
Post #:39756955
Post #:40284097
Post #:40284785
-Process circuitry looks relatively basic which is good.
-Recoveries of 76% seems are probably realistic - If their met test's are analogous to the JORC ore body this should be achievable.
-LOM pricing of 690 USD - Still a fair bit higher than current pricing but around where i would say it will average so no issues there.
-IRR/NPV is little low as stated with NPV8 but fairly as expected with 2mtpa throughput. I garner there will be stage 2 upgrades in the future and there is obviously more ore around to support a longer mine life. Increasing the NPV.
Sensitivity analysis is usually the best go to.
Can be seen that recoveries halve the NPV if only achieving 65% if spod price hold at 600USD probably becomes marginal. This is what has occurred with most current producers.
All in all - It seems quite realistic and economical.
Best of luck everyone - hopefully the market likes it.
SF2T
- Forums
- ASX - By Stock
- LTR
- Ann: PFS confirms potential for robust new long-life lithium mine
Ann: PFS confirms potential for robust new long-life lithium mine, page-12
-
-
- There are more pages in this discussion • 198 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LTR (ASX) to my watchlist
(20min delay)
|
|||||
Last
97.0¢ |
Change
-0.030(3.00%) |
Mkt cap ! $2.418B |
Open | High | Low | Value | Volume |
$1.03 | $1.03 | 97.0¢ | $10.18M | 10.22M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 110711 | 97.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
97.5¢ | 249770 | 34 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 242965 | 0.970 |
11 | 270467 | 0.965 |
12 | 179443 | 0.960 |
11 | 694955 | 0.955 |
31 | 251036 | 0.950 |
Price($) | Vol. | No. |
---|---|---|
0.975 | 169565 | 21 |
0.980 | 196467 | 18 |
0.985 | 179089 | 14 |
0.990 | 234558 | 10 |
0.995 | 196976 | 8 |
Last trade - 15.28pm 15/07/2024 (20 minute delay) ? |
Featured News
LTR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online